{
  "id": 2619452,
  "title": "A real-world study of Oregon's nonmedical psilocybin program shows promise",
  "url": "https://urgent.news/2026/08/19/a-real-world-study-of-oregons-nonmedical-psilocybin-program-shows",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T18:00:00.000Z",
  "source": {
    "name": "Discovered",
    "slug": "discovered",
    "url": "https://wfdd.org/national/2026-08-19/a-real-world-study-of-oregons-nonmedical-psilocybin-program-shows-promise"
  },
  "original_language": "en",
  "account": "A recent study of Oregon's nonmedical psilocybin program reveals a largely positive outlook. Conducted by Oregon Health & Science University, the research analyzed the experiences of nearly 350 individuals who took the drug at state-licensed centers. Most participants reported their trip as beneficial, and over half described it as one of the most meaningful experiences of their lives. The data suggests the program was overall quite safe, with only a very small number of participants experiencing serious adverse reactions. Dr. Todd Korthuis, who led the research team, expressed initial skepticism about administering psilocybin outside of a tightly controlled medical setting, but the data has since convinced him. The study represents a different pathway for psychedelics, as it focuses on real-world implications rather than drug development trials aimed at FDA approval for mental health conditions. The findings are seen as particularly encouraging, given that the number of adverse events is roughly what one would expect from other psychiatric interventions. While some participants experienced behavioral health issues, such as violent reactions and thoughts of dying or suicide, these were mostly among first-time users. The study's demographic makeup closely mirrors that of those who have visited Oregon's licensed psilocybin service centers, located mainly in Portland. However, the researchers caution against generalizing the results to everyone, as the sample is relatively small and the participants are mostly white and college-educated, with a third having a household income over $200,000. Korthuis and his team plan to track a larger sample as part of the OPEN initiative, but he remains confident that the results can be generalized and bode well for the future of a regulated psychedelic industry.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}